Patents by Inventor Jae Gap Kim

Jae Gap Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for promoting bone tissue formation, containing leaf extract as active ingredient
    Patent number: 10328110
    Abstract: The present invention relates to a composition for promoting osteoblast or cartilage cell differentiation. More particularly, the present invention relates to a composition, which includes stauntonia hexaphylla leaf extract that may be safely used without toxicity and side effects by using a natural ingredient, for promoting bone (tissue) formation to be used for suppressing and treating bone and cartilage tissue damage. A pharmaceutical composition including the stauntonia hexaphylla leaf extract according to the present invention as an active ingredient may be used as a medicine for periodontitis or osteoporosis to treat or prevent periodontitis or osteoporosis.
    Type: Grant
    Filed: April 29, 2014
    Date of Patent: June 25, 2019
    Assignees: JEONNAM BIOINDUSTRY FOUNDATION, YUNGJIN PHARMACEUTICAL CO., LTD.
    Inventors: Chul Yung Choi, Sang O Pan, Hee Jin Seol, Gyu Ok Lee, Wook Jin Jang, Hee Sook Kim, Jae Yong Kim, HuWon Kang, Dong Wook Lee, Sun Oh Kim, Jae Gap Kim, JoonYung Park
  • MEDICAL COMPOSITION CONTAINING STAUNTONIA HEXAPHYLLA EXTRACT
    Publication number: 20160193265
    Abstract: Disclosed is an antipyretic drug comprising a Stauntonia Hexaphylla leaf extract as an active ingredient. The antipyretic drug is developed based on the finding that the Stauntonia Hexaphylla leaf extract has no cytotoxicity and exhibits superior antipyretic effects, as compared to conventional antipyretic drugs having antipyretic effects. An antipyretic composition comprising the Stauntonia Hexaphylla leaf extract as an active ingredient exhibits potent antipyretic effect.
    Type: Application
    Filed: February 1, 2016
    Publication date: July 7, 2016
    Applicants: Jeonnam Bioindustry Foundation, YUNGJIN PHARM.CO., LTD.
    Inventors: Chul Yung CHOI, Sang O PAN, Hee Jin SEOL, Gyu Ok LEE, Ka Hyon PARK, Hee Sook KIM, Wook Jin JANG, Hyun KIM, Dong Wook LEE, Sun Oh KIM, Jae Gap KIM
  • Medical composition containing extract
    Patent number: 9370542
    Abstract: Disclosed is an antipyretic drug comprising a Stauntonia Hexaphylla leaf extract as an active ingredient. The antipyretic drug is developed based on the finding that the Stauntonia Hexaphylla leaf extract has no cytotoxicity and exhibits superior antipyretic effects, as compared to conventional antipyretic drugs having antipyretic effects. An antipyretic composition comprising the Stauntonia Hexaphylla leaf extract as an active ingredient exhibits potent antipyretic effect.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: June 21, 2016
    Assignees: JEONNAM BIOINDUSTRY FOUNDATION, YUNGJIN PHARM.CO., LTD.
    Inventors: Chul Yung Choi, Sang O Pan, Hee Jin Seol, Gyu Ok Lee, Ka Hyon Park, Hee Sook Kim, Wook Jin Jang, Hyun Kim, Dong Wook Lee, Sun Oh Kim, Jae Gap Kim
  • PHARMACEUTICAL COMPOSITION FOR PROMOTING BONE TISSUE FORMATION, CONTAINING STAUNTONIA HEXAPHYLLA LEAF EXTRACT AS ACTIVE INGREDIENT
    Publication number: 20160113979
    Abstract: The present invention relates to a composition for promoting osteoblast or cartilage cell differentiation. More particularly, the present invention relates to a composition, which includes stauntonia hexaphylla leaf extract that may be safely used without toxicity and side effects by using a natural ingredient, for promoting bone (tissue) formation to be used for suppressing and treating bone and cartilage tissue damage. A pharmaceutical composition including the stauntonia hexaphylla leaf extract according to the present invention as an active ingredient may be used as a medicine for periodontitis or osteoporosis to treat or prevent periodontitis or osteoporosis.
    Type: Application
    Filed: April 29, 2014
    Publication date: April 28, 2016
    Applicants: YUNGJIN PHARMACEUTICAL CO., LTD., Jeonnam Bioindustry Foundation
    Inventors: Chul Yung CHOI, Sang O PAN, Hee Jin SEOL, Gyu Ok LEE, Wook Jin JANG, Hee Sook KIM, Jae Yong KIM, HuWon KANG, Dong Wook LEE, Sun Oh KIM, Jae Gap KIM, JoonYung PARK
  • MEDICAL COMPOSITION CONTAINING STAUNTONIA HEXAPHYLLA EXTRACT
    Publication number: 20140205691
    Abstract: Disclosed is an antipyretic drug comprising a Stauntonia Hexaphylla leaf extract as an active ingredient. The antipyretic drug is developed based on the finding that the Stauntonia Hexaphylla leaf extract has no cytotoxicity and exhibits superior antipyretic effects, as compared to conventional antipyretic drugs having antipyretic effects. An antipyretic composition comprising the Stauntonia Hexaphylla leaf extract as an active ingredient exhibits potent antipyretic effect.
    Type: Application
    Filed: May 16, 2012
    Publication date: July 24, 2014
    Applicants: YUNGJIN PHARM.CO., LTD., JEONNAM BIOINDUSTRY FOUNDATION
    Inventors: Chul Yung Choi, Sang O Pan, Hee Jin Seol, Gyu Ok Lee, Ka Hyon Park, Hee Sook Kim, Wook Jin Jang, Hyun Kim, Dong Wook Lee, Sun Oh Kim, Jae Gap Kim